The Broad Institute's Edward Scolnick, MD, the former head of research at drug manufacturer Merck, will give the first lecture in the School of Science's Dean's Colloquium, a new series of lectures created to recognize scientists with interesting and unusual career paths. The inaugural lecture, hosted by Marc Kastner, dean of the School of Science, will be held at 4 p.m. Thursday, Oct. 22, in 26-100.
In his talk, "The Power of Basic Science Applied to Medical Progress: Past Examples and the Hope for Schizophrenia and Bipolar Illness," Dr. Scolnick will share his experience with the dramatic changes basic science can make in the field of medical research, as well as promising current research in the field of severe mental illness.
After making influential discoveries in the genetics of cancer during 15 years at the National Institutes of Health, Dr. Scolnick spent 22 years at Merck Research Laboratories overseeing the discovery, development, and approval of nearly 20 new medicines. Currently, he is a professor of the practice in MIT's Department of Biology and director of the Psychiatric Disease Program and the Stanley Center for Psychiatric Research at the Broad Institute.
For more information: email@example.com or 3-8055.